A few facts on RT001- Topical Botox:
- Has been shown to produce significant improvement in the crow’s feet wrinkles in 89% of the 553 patients already treated
- Similar to the injectiable form, the gel relaxes the muscles responsible for causing skin wrinkles beneath the skin
- Is not yet FDA approved and therefore will not be available until 2013 or 2014
- Preliminary results are significant and exciting, but not quite as successful as traditional injectable Botox
- Results of topical Botox have proved to last up to three months
After reviewing the results of the studies on RT001, Dr. Rucker is hopeful it will deliver as promised. He has many patients that want the results of Botox, but refrain from it due to needle phobia. In the meantime, he strongly recommends Tri-Peptide Cell Activator as an effective alternative. Where Botox relaxes the muscles that cause wrinkles, the Tri-Peptide Cell Activator stimulates collagen production to plump the fine lines and creases. So if you are wary of needles, the Tri-Peptide Cell Activator just might be your new best friend.